RT Journal Article
SR Electronic
T1 Medical Expectations Survey on Artificial Intelligence Solutions in daily practice
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.06.29.23291561
DO 10.1101/2023.06.29.23291561
A1 Giavina-Bianchi, Mara
A1 Amaro, Edson
A1 Machado, Birajara Soares
YR 2023
UL http://medrxiv.org/content/early/2023/06/29/2023.06.29.23291561.abstract
AB Background Artificial intelligence (AI) applied to Medicine has become one of the hottest topics for the past years. Although scarcely used in real practice, it brings along many expectations, doubts and fears for physicians. Surveys can help to understand this situation.Objective To explore the degree of knowledge, expectations, fears and daily practice questions on AI use by physicians.Methods an electronic survey was sent to physicians of a large hospital in Brazil, from August-September 2022.Results 171 physicians responded to our survey. 54% considered themselves to have an intermediate knowledge of AI. 79% believe AI should be regulated by a Governmental Agency. If AI were reliable and available, 78% intend to use AI frequently/always for diagnosis (87%) and/or management (83%), but they were unsure about the use of AI by other health professionals (50%) or by the patients (51%). The main benefit would be increasing the speed for diagnosis and management (64%), and the worst issue, to over rely on AI and lose medical skills (71%). Physicians believe AI would be useful (94%), facilitate the work (87%), increase the number of appointments (54%), not interfere in the financial gain (58%) and not replace their jobs, but, rather, be utilized as an additional source of information (65%). In case of disagreement between AI and physicians, most answered that a third opinion should be requested (86%). There were no significant differences between the physicians’ answers according to time since graduation.Conclusions physicians showed to have good expectations regarding the use of AI in Medicine when applied by themselves, but not so much by others. They also have intention to use it, as long as it was approved by a Regulatory Agency. Although there was hope for the beneficial impact of AI on healthcare, it also brings specific concerns.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Ethics Committee of Hospital Israelita Albert Einstein (CAAE: 30749620.6.0000.0071).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors